Drugs / BETAMETHASONE DIPROPIONATE
BETAMETHASONE DIPROPIONATE
also known as
Compound Betamethasone · Alphatrex · Betamethasone (as dipropionate) · Betamethasone 17,21-dipropionate · Betamethasone dipropionate component of enstilar · Betamethasone dipropionate component of leo-90100 · Betamethasone dipropionate component of lotrisone · Betamethasone dipropionate component of taclonex · +9 more
Small molecule targets NR3C1 via activation
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT06626568 | Oct 2024 → Aug 2025 | frozen shoulder | Second Affiliated Hospital, School of Medicine, Zhejiang University | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT07668895 | Jul 2026 → Jul 2027 expected | pulmonary sarcoidosis | Peking Union Medical College Hospital | Not yet recruiting | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT07416916 | Feb 2026 → Oct 2030 expected | frozen shoulder | Second Affiliated Hospital, School of Medicine, Zhejiang University | Recruiting | No outcome recorded |
| Phase 4 | NCT04931511 | Jun 2021 → Sep 2022 | bursitis, frozen shoulder | Second Affiliated Hospital, School of Medicine, Zhejiang University | Terminated | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07835438 | Apr 2025 → Jun 2026 overdue | keloid | First Hospital of China Medical University | Active not recruiting | No outcome recorded |
| Comparator or background therapy6 trials | ||||||
| Phase 1/2 | NCT05588908 Comparator | Jun 2022 → Sep 2023 | gout | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Unknown | No outcome recorded |
| Phase 2 | NCT07453004 Comparator | Mar 2026 → Dec 2027 expected | gout | TJ Biopharma Co., Ltd. | Recruiting | No outcome recorded |
| Phase 2 | NCT03300531 Comparator | Dec 2017 → Dec 2020 | epicondylitis, rotator cuff syndrome, tendinitis | Second Affiliated Hospital, School of Medicine, Zhejiang University | Unknown | No outcome recorded |
| Phase 3 | NCT06169891 Comparator | Dec 2023 → Dec 2024 | gout | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Unknown | No outcome recorded |
| Phase 4 | NCT03215407 Comparator | Aug → Dec 2017 | rheumatoid arthritis | Chinese PLA General Hospital | Unknown | No outcome recorded |
| — | NCT07348016 Comparator | Aug 2025 → Jul 2027 expected | rotator cuff syndrome | Second Affiliated Hospital of Nanchang University | Recruiting | No outcome recorded |
Press releases naming this drug 3 releases
| Date | Issuer | Release |
|---|---|---|
| 2020-07-16 | MC2 Therapeutics | MC2 Therapeutics Announces Submission of Marketing Authorization Application in EU for Wynzora® Cream (50 µg/g calcipotriol and 0.5 mg/g betamethasone (as dipropionate) mc2therapeutics.com ↗ |
| 2020-03-20 | Lupin Limited | Lupin launches Betamethasone Dipropionate Ointment USP (Augmented) lupin.com ↗ |
| 2019-12-19 | Lupin Limited | Lupin receives approval for Betamethasone Dipropionate Ointment USP (Augmented) lupin.com ↗ |
Evidence & citations 22 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BETAMETHASONE DIPROPIONATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200384 ↗ |
| Known as | Alphatrex | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200384 ↗ |
| Known as | Betamethasone (as dipropionate) | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200384 ↗ |
| Known as | Betamethasone 17,21-dipropionate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200384 ↗ |
| Known as | Betamethasone dipropionate component of enstilar | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200384 ↗ |
| Known as | Betamethasone dipropionate component of leo-90100 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200384 ↗ |
| Known as | Betamethasone dipropionate component of lotrisone | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200384 ↗ |
| Known as | Betamethasone dipropionate component of taclonex | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200384 ↗ |
| Known as | Betamethasone dipropionate component of wynzora | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200384 ↗ |
| Known as | Compound Betamethasone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07668895 ↗ |
| Known as | Diprolene | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200384 ↗ |
| Known as | Diprolene af | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200384 ↗ |
| Known as | Diprosone | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200384 ↗ |
| Known as | Diprospan | “Compound Betamethasone (also known as Diprospan)” NCT07668895 ↗ |
| Known as | Maxivate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200384 ↗ |
| Known as | NSC-758415 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200384 ↗ |
| Known as | Rinderon dp | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200384 ↗ |
| Known as | SCH 11460 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1200384 ↗ |
| Action | Activate | “Glucocorticoid receptor agonist” CHEMBL1200384 ↗ |
| Modality | Small molecule | — CHEMBL1200384 ↗ |
| Route | Other | “14mg intra-articular” NCT03215407 ↗ |
| Target | NR3C1 | “Glucocorticoid receptor agonist” CHEMBL1200384 ↗ |